Elliot Hershberg

Elliot Hershberg is a biotech scientist, writer, and investor. He has helped design cancer vaccines, built computational tools for spatial genomics technologies, and worked as a software engineer on a modern genome browser. Elliot writes the Century of Biology newsletter covering new data, companies, and ideas from the frontier of biology. He is also the Biotech Partner at Not Boring Capital, where he actively invests in businesses accelerating synthetic biology.

Century of Biology
Monday
May 05
Introduction to Synthetic Biology - Pre-Conference Course
1:00 PM

-

5:00 PM

*Separate registration required Curious about synthetic biology but don’t have a science background? This seminar is for you. Join us for a dynamic, half-day journey into the world of engineering biology—designed specifically for executives, investors, policymakers, and the “biocurious.” You’ll learn how scientists are programming living systems to create everything from chemicals and fuels to food, materials, and medicine.

Tuesday
May 06
Reprogramming Biology at Cloud Speed
4:30 PM

-

5:15 PM

Biotech is accelerating—and cloud infrastructure is the catalyst. This session explores how scalable compute, AI-native architectures, and real-time data integration are transforming the way biology is engineered. From protein design to genome editing, discover how innovators are leveraging cloud-native platforms to run complex simulations, automate workflows, and shorten the cycle from hypothesis to insight. Hear from leaders building the tools that are making biology programmable, iterative, and as fast as software development.

Thursday
May 08
Applied AI for Biomanufacturing: Challenges, Opportunities, and Real-World Impact
1:30 PM

-

2:15 PM

Artificial intelligence is already reshaping biomanufacturing, challenging long-standing practices and driving new levels of productivity. But what does this transformation look like in practice? This session offers a candid, hype-free discussion on the real-world impact of AI in biomanufacturing today. Industry experts will explore how AI is accelerating production, reducing costs, and enabling rapid scale-up—while also addressing the technical, organizational, and regulatory barriers that remain. Through real case studies and practical insights, we’ll examine what’s working, what isn’t, and what lessons can be drawn from current deployments. Join us for an honest look at the challenges, opportunities, and future direction of applied AI in the bioeconomy.

Other Speakers